1 October 2021 in Science Advances
Age-based COVID-19 vaccination prioritizes white people above higher-risk others; geographic prioritization improves equity.
10 December 2022 in International Journal of Infectious Diseases
The COVID-19 pandemic is characterized by successive waves that each developed differently over time and through space. We aim to provide an in-depth analysis of the evolution of COVID-19 mortality during 2020 and 2021 in a selection of countries. We focus on five European countries and the United States. Using standardized and age-specific mortality rates, we address variations in COVID-19 mortality within and between countries, and demographic characteristics and seasonality patterns. Our results highlight periods of acceleration and deceleration in the pace of COVID-19 mortality, with substantial differences across countries. Periods of stabilization were identified during summer (especially in 2020) among the European countries analyzed but not in the United States. The latter stands out as the study population with the highest COVID-19 mortality at young ages. In general, COVID-19 mortality is highest at old ages, particularly during winter. Compared with women, men have higher COVID-19 mortality rates at most ages and in most seasons. There is seasonality in COVID-19 mortality for both sexes at all ages, characterized by higher rates during winter. In 2021, the highest COVID-19 mortality rates continued to be observed at ages 75+, despite vaccinations having targeted those ages specifically.
1 October 2019 in Population & Sociétés
Aux États-Unis, l’espérance de vie à la naissance a cessé d’augmenter à partir de 2010 et elle a même diminué chez les hommes depuis 2014. Le décrochement des États-Unis par rapport aux autres pays de l’OCDE a commencé vers 1980 et il s’est aggravé. Les progrès dans la lutte contre les maladies cardiovasculaires, en grande partie responsables de la hausse de l’espérance de vie au cours des années 1970 et 1980, ont ralenti depuis 2000 en lien notamment avec la croissance de l’obésité et du diabète. L’épidémie d’overdoses de drogues explique la moitié des années de vie perdues entre 2014 et 2017. La mortalité due à cette cause a été multipliée par plus de cinq entre 1980 et 2017.
22 February 2022 in The Journals of Gerontology, Series B: Psychological Sciences and Social Sciences
Objectives: The articles examines the contribution of internal socioeconomic disparities in mortality to the U.S. international disadvantage in life expectancy at birth. Methods: Using individual death records from the U.S. national vital statistics system for years 1982–2019 and data for other countries from the Human Mortality Database, we compare age-specific death rates and life expectancy between counties classified into 10 socioeconomic categories and 20 high-income countries. We also calculate the number of years of life lost in each socioeconomic decile in relation to the comparison set. Results: There is a clear and increasing socioeconomic gradient of mortality in the United States, but the growing divergence in internal mortality trends does not explain the rising gap between the country and its peers. In 2019, even American women in the most socioeconomically advantaged decile lived shorter lives, while only 10% of men in the most affluent decile fared better than their peers. The long-standing U.S. disadvantage in young adult mortality has been growing and the country’s previous advantage in mortality at ages 75 years and older has virtually disappeared for all but for Americans in the most affluent counties. Discussion: The similar age pattern of differences in mortality rates between each socioeconomic deciles and the comparison group suggests that the underlying factors might be the same. The role of external causes (including drug overdoses) for middle-aged adults and a slowing down in progress to control cardiovascular diseases at older ages at the national level are consistent with this pattern.
10 January 2025 in Demographic Research
Volume 52 - Article 3 | Pages 71–110